IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.596
-0.078 (-4.66%)
Mar 5, 2026, 9:24 AM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 142.19 million as of March 4, 2026. Its market cap has decreased by -79.92% in one year.
Market Cap
142.19M
Enterprise Value
90.28M
Revenue
57.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 142.19M, a decrease of -65.57%. That is a compound annual growth rate of -11.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 142.19M | -15.03% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sprint Bioscience AB | 196.26M |
| Initiator Pharma | 195.09M |
| Isofol Medical AB | 193.96M |
| Magle Chemoswed Holding AB | 163.13M |
| NextCell Pharma AB | 145.03M |
| Simris Group AB (PUBL) | 134.98M |
| Active Biotech AB | 126.53M |
| Xbrane Biopharma AB | 122.00M |